Patient satisfaction, sexual function and decision regret in use of levonorgestrel intrauterine device-Reference-Cited by-同舟云学术

Patient satisfaction, sexual function and decision regret in use of levonorgestrel intrauterine device

Published:2023-03-27 Issue:2 Volume:5 Page:111-119
ISSN:2718-0115
Container-title:Anatolian Current Medical Journal
language:
Short-container-title:

Author:

SATIR ÖZEL Canan¹^ORCID,İNANÇ KARAMAN Gökçem Büşra²^ORCID,DEMİRÇİVİ Ergül³^ORCID,YARDIMCI Oğuz⁴^ORCID,ÇAKIR Mustafa⁵^ORCID,TURGUT Abdulkadir³^ORCID

Affiliation:

1. Medeniyet Üniversitesi Göztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesi

2. İstanbul Medeniyet Üniversitesi, Göztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesi, Kadın Hastalıkları ve Doğum Anabilim Dalı

3. İSTANBUL MEDENİYET ÜNİVERSİTESİ, TIP FAKÜLTESİ, CERRAHİ TIP BİLİMLERİ BÖLÜMÜ, KADIN HASTALIKLARI VE DOĞUM ANABİLİM DALI

4. İstanbul Medeniyet Üniversitesi, Göztepe Prof Dr Süleyman Yalçın Şehir Hastanesi, Kadın Hastalıkları ve Doğum Anabilim Dalı

5. İSTANBUL MEDENİYET ÜNİVERSİTESİ, TIP FAKÜLTESİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ, HALK SAĞLIĞI ANABİLİM DALI

Abstract

Aim: Abnormal uterine bleeding is a common condition. The etiological cause and treatments are diverse. LNG-IUD can be used to treat abnormal uterine bleeding.It has been shown to reduce the amount of bleeding in patients with menorrhagia and increase hemoglobin and hematocrit (Hct) values. The aim is to investigate the effects of LNG-IUD on hemoglobin, Hct, bleeding pattern, and its effect on sexual function, decision regret, and menorrhagia effects according to the etiologic cause. Material and Method: Our study included patients who underwent LNG-IUD implantation and had been using it for over six months. Patients with a history of postmenopausal or adolescent bleeding, hematologic or oncologic diseases, and a history of drug use that may cause coagulation disorders were excluded. Patients were grouped according to their indications as polyp (n=26), adenomyosis (n=16), leiomyoma (n=27), hyperplasia (n=18), and non-structural causes (n=81). Hemoglobin (Hb) and Hct values were examined before and after the application, and bleeding patterns were questioned. Participants were administered Menorrhagia Impact Questionnaire (MIQ), Arizona Sexual Experience Scale and Decision Regret Scale. Results: 168 patients were included in our study. The average duration of LNG-IUD use was 627.0±319 days and the average age was 43.4±6.1 years. The frequency of bleeding (number of bleedings per year) was 18.0±8.0 before LNG-IUD application and 7.8±8.0 after treatment (p

Publisher

Anatolian Current Medical Journal

Subject

General Medicine

Reference33 articles.

1. Liu Z, Doan Q, Blumenthal P, Dubois RW. A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in abnormal uterine bleeding. Value Health 2007; 10: 183–94.

2. Fraser IS, Critchley HOD, Broder M, Munro MG. The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding. Semin Reprod Med 2011; 29: 383–90.

3. Heavy menstrual bleeding: assessment and management. National Institute for Health and Care Excellence (NICE), Clinical Guidelines Vol. 29, 2018, London.

4. Kaunitz AM, Bissonnette F, Monteiro I, Lukkari-Lax E, DeSanctis Y, Jensen J. Levonorgestrel-Releasing Intrauterine System for heavy menstrual bleeding improves hemoglobin and ferritin levels. Contraception 2012; 86: 452–457.

5. Munro MG, Critchley HOD, Broder MS, Fraser IS, FIGO Working Group on Menstrual Disorders. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet 2011; 113: 3–13.